Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lowes

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Journal of Molecular and Cellular Cardiology|July 9, 2002
Altered expression of endothelin receptors in failing human left ventriclesKoji Asano, Teresa J Bohlmeyer, Jay Y Westcott, et al.
The Journal of Clinical Investigation|December 31, 1997
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardiumB D Lowes, W Minobe, W T Abraham, et al.
JCI Insight|August 22, 2023
An extensive β1-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathiesPhilip D Tatman, David P Kao, Kathryn C Chatfield, et al.
Journal of Cardiac Failure|December 20, 2005
Rationale and design of the enoximone clinical trials programBrian D Lowes, Simon F Shakar, Marco Metra, et al.
Circulation|September 1, 2004
Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trialM R Bristow, H Krause-Steinrauf, R Nuzzo, et al.
Circulation|October 26, 2020
Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point ResultsEmma J Birks, Stavros G Drakos, Snehal R Patel, et al.
Circulation. Heart Failure|November 3, 2009
An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failureMichael R Bristow, Guinevere A Murphy, Heidi Krause-Steinrauf, et al.
JAMA Cardiology|January 16, 2020
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical TrialDaniel J Goldstein, Yoshifumi Naka, Douglas Horstmanshof, et al.
Molecular Medicine (Cambridge, Mass.)|January 10, 2003
Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotypeW T Abraham, E M Gilbert, B D Lowes, et al.
American Heart Journal|September 27, 2020
PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failureRobert J Mentz, Haolin Xu, Emily C O'Brien, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Molecular and Cellular Cardiology|July 9, 2002
Altered expression of endothelin receptors in failing human left ventriclesKoji Asano, Teresa J Bohlmeyer, Jay Y Westcott, et al.
The Journal of Clinical Investigation|December 31, 1997
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardiumB D Lowes, W Minobe, W T Abraham, et al.
JCI Insight|August 22, 2023
An extensive β1-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathiesPhilip D Tatman, David P Kao, Kathryn C Chatfield, et al.
Journal of Cardiac Failure|December 20, 2005
Rationale and design of the enoximone clinical trials programBrian D Lowes, Simon F Shakar, Marco Metra, et al.
Circulation|September 1, 2004
Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trialM R Bristow, H Krause-Steinrauf, R Nuzzo, et al.
Circulation|October 26, 2020
Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point ResultsEmma J Birks, Stavros G Drakos, Snehal R Patel, et al.
Circulation. Heart Failure|November 3, 2009
An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failureMichael R Bristow, Guinevere A Murphy, Heidi Krause-Steinrauf, et al.
JAMA Cardiology|January 16, 2020
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical TrialDaniel J Goldstein, Yoshifumi Naka, Douglas Horstmanshof, et al.
Molecular Medicine (Cambridge, Mass.)|January 10, 2003
Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotypeW T Abraham, E M Gilbert, B D Lowes, et al.
American Heart Journal|September 27, 2020
PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failureRobert J Mentz, Haolin Xu, Emily C O'Brien, et al.
Pageof 11